We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News   Jul 27, 2017 | Original story from NIH

 
FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

Credit: Christaras A, CC BY 2.5

 
 
 

RELATED ARTICLES

Research Outlines How Drug in Clinical Trial for Coronavirus Works

News

A new study published in the Journal of Biological Chemistry outlines how an antiviral drug that is currently being tested in patients with the novel coronavirus (COVID-19), remdesivir, works.

READ MORE

Existing Drugs Could Be Key To Combatting Coronavirus Outbreak

News

Developing new drugs and vaccines to treat the coronavirus that causes COVID-19 can take years. Existing drugs may offer a possible quick response to the potential pandemic.

READ MORE

SNIPRs Take Aim at Disease-related Mutations

News

A new method for detecting point mutations has been developed which can be applied in living cells, offering a rapid, highly accurate and inexpensive means of identifying mutations relevant to human health.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE